268 related articles for article (PubMed ID: 18291711)
41. Tuberous sclerosis complex 2 loss-of-function mutation regulates reactive oxygen species production through Rac1 activation.
Suzuki T; Das SK; Inoue H; Kazami M; Hino O; Kobayashi T; Yeung RS; Kobayashi K; Tadokoro T; Yamamoto Y
Biochem Biophys Res Commun; 2008 Mar; 368(1):132-7. PubMed ID: 18230340
[TBL] [Abstract][Full Text] [Related]
42. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
van Slegtenhorst M; Nellist M; Nagelkerken B; Cheadle J; Snell R; van den Ouweland A; Reuser A; Sampson J; Halley D; van der Sluijs P
Hum Mol Genet; 1998 Jun; 7(6):1053-7. PubMed ID: 9580671
[TBL] [Abstract][Full Text] [Related]
43. Hamartin and tuberin modulate gene transcription via beta-catenin.
Jozwiak J; Wlodarski P
J Neurooncol; 2006 Sep; 79(3):229-34. PubMed ID: 16552619
[TBL] [Abstract][Full Text] [Related]
44. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
[TBL] [Abstract][Full Text] [Related]
45. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
[TBL] [Abstract][Full Text] [Related]
46. Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC/mTOR signaling.
Han S; Witt RM; Santos TM; Polizzano C; Sabatini BL; Ramesh V
Cell Signal; 2008 Jun; 20(6):1084-91. PubMed ID: 18308511
[TBL] [Abstract][Full Text] [Related]
47. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
[TBL] [Abstract][Full Text] [Related]
48. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
[TBL] [Abstract][Full Text] [Related]
49. p27Kip1 localization depends on the tumor suppressor protein tuberin.
Rosner M; Freilinger A; Hanneder M; Fujita N; Lubec G; Tsuruo T; Hengstschläger M
Hum Mol Genet; 2007 Jul; 16(13):1541-56. PubMed ID: 17470459
[TBL] [Abstract][Full Text] [Related]
50. Dissociate expression of tuberous sclerosis complex 1 product hamartin in a skin and pulmonary lesion of a tuberous sclerosis complex.
Wataya-Kaneda M; Katayama I
Hum Pathol; 2009 Mar; 40(3):430-4. PubMed ID: 18835623
[TBL] [Abstract][Full Text] [Related]
51. CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?
Rosner M; Dolznig H; Fuchs C; Siegel N; Valli A; Hengstschläger M
Eur J Clin Invest; 2009 Dec; 39(12):1033-5. PubMed ID: 19744185
[TBL] [Abstract][Full Text] [Related]
52. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
53. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
[TBL] [Abstract][Full Text] [Related]
54. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
[TBL] [Abstract][Full Text] [Related]
55. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.
Gutmann DH; Zhang Y; Hasbani MJ; Goldberg MP; Plank TL; Petri Henske E
Acta Neuropathol; 2000 Mar; 99(3):223-30. PubMed ID: 10663963
[TBL] [Abstract][Full Text] [Related]
56. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
[TBL] [Abstract][Full Text] [Related]
57. TSC2, a key player in tumor suppression and cystic kidney disease.
Cai SL; Walker CL
Nephrol Ther; 2006 Jan; 2 Suppl 2():S119-22. PubMed ID: 17373211
[TBL] [Abstract][Full Text] [Related]
58. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
[TBL] [Abstract][Full Text] [Related]
59. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
[TBL] [Abstract][Full Text] [Related]
60. Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin.
Yamamoto Y; Jones KA; Mak BC; Muehlenbachs A; Yeung RS
Arch Biochem Biophys; 2002 Aug; 404(2):210-7. PubMed ID: 12147258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
